BCAN Launches My Bladder Cancer Story

February 21, 2017
by Stephanie Chisolm

This year, over 79,000 people will be diagnosed with bladder cancer. BCAN understands that there are real people behind this number. Our ‘My Bladder Cancer Story’ Campaign presents stories to raise awareness and call attention to the lives and daily experiences of bladder cancer patients and families nationwide. Read the stories            Share your Story Share this page:

Read More...

Join BCAN for a New Discoveries Research Lecture in Palm Beach March 8th, 2017

February 8, 2017
by Stephanie Chisolm

On March 8th, 2017 the Bladder Cancer Advocacy Network New Discoveries Research Luncheon & Lecture will give attendees a glimpse into some of the new treatments used to combat the fifth most commonly diagnosed cancer in the country. The lecture and luncheon will take place at The Beach Club in Palm Beach, Florida, and will feature Dr. David McConkey, Director of Johns Hopkins Greenberg Bladder Cancer Institute, who will highlight promising new bladder cancer treatments, as well as Fay Vincent, former Major League Baseball Commissioner, and bladder cancer survivor who will share his personal journey. 11:30 AM-1:30 PM, Wednesday, March 8, 2017 at The…

Read More...

BMS Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma

February 3, 2017
by Stephanie Chisolm

BCAN applauds the U.S. Food and Drug Administration (FDA) for approving Opdivo for use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. “Although bladder cancer is the 5th most commonly diagnosed cancer in the United States, it is only recently that we are starting to see new treatments being approved to help patients with this disease,” according to Andrea Maddox-Smith, CEO of BCAN.  “The FDA’s approval of Opdivo offers a much-needed treatment option for the…

Read More...